Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.

OVERLAP
37%
OVERLAP
BY WEIGHT
13
# OF OVERLAPPING
HOLDINGS
MEDX
28
HOLDINGS
46%
ALSO IN FTXH
FTXH
51
HOLDINGS
27%
ALSO IN MEDX
SECTOR DRIFT (MEDX minus FTXH)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in MEDX |
Weight in FTXH |
Overlap | |
---|---|---|---|---|
ABBVIE INC | 9.4% | 7.6% | 7.6% | |
JOHNSON & JOHNSON | 5.0% | 7.6% | 5.0% | |
BRISTOL-MYERS SQUIBB CO | 3.9% | 6.4% | 3.9% | |
ELI LILLY & CO | 14.4% | 3.8% | 3.8% | |
AMGEN INC | 3.8% | 3.6% | 3.6% |
MEDX Overweight Relative to FTXH
ELI LILLY & CO | 10.6% | |
NOVARTIS AG-ADR | 6.7% | |
ALNYLAM PHARMACEUTICALS INC | 5.9% | |
ASTRAZENECA PLC-SPONS ADR | 5.2% | |
IONIS PHARMACEUTICALS, INC. | 4.1% | |
CRISPR THERAPEUTICS AG | 3.9% | |
ALKERMES PLC | 2.8% | |
GLAXOSMITHKLINE PLC-SPON ADR | 2.6% | |
INTELLIA THERAPEUTICS, INC. | 1.9% | |
ABBVIE INC | 1.8% |
MEDX Underweight Relative to FTXH
MERCK & CO. INC. | -4.0% | |
GILEAD SCIENCES INC | -3.8% | |
VERTEX PHARMACEUTICALS INC | -3.7% | |
CARDINAL HEALTH INC | -3.7% | |
PFIZER INC | -3.5% | |
UNITED THERAPEUTICS CORP | -3.4% | |
ZOETIS INC | -3.2% | |
VIATRIS, INC. | -3.2% | |
JOHNSON & JOHNSON | -2.6% | |
BRISTOL-MYERS SQUIBB CO | -2.5% |